220 related articles for article (PubMed ID: 22737189)
1. Imaging of adrenal masses with emphasis on adrenocortical tumors.
Sundin A
Theranostics; 2012; 2(5):516-22. PubMed ID: 22737189
[TBL] [Abstract][Full Text] [Related]
2. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.
Hennings J; Hellman P; Ahlström H; Sundin A
Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990
[TBL] [Abstract][Full Text] [Related]
3. Imaging of adrenal incidentalomas with PET using (11)C-metomidate and (18)F-FDG.
Minn H; Salonen A; Friberg J; Roivainen A; Viljanen T; Långsjö J; Salmi J; Välimäki M; Någren K; Nuutila P
J Nucl Med; 2004 Jun; 45(6):972-9. PubMed ID: 15181132
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.
Zettinig G; Mitterhauser M; Wadsak W; Becherer A; Pirich C; Vierhapper H; Niederle B; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2004 Sep; 31(9):1224-30. PubMed ID: 15197504
[TBL] [Abstract][Full Text] [Related]
5. [11C]metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings.
Hennings J; Lindhe O; Bergström M; Långström B; Sundin A; Hellman P
J Clin Endocrinol Metab; 2006 Apr; 91(4):1410-4. PubMed ID: 16403816
[TBL] [Abstract][Full Text] [Related]
6. Metomidate-based imaging of adrenal masses.
Hahner S; Sundin A
Horm Cancer; 2011 Dec; 2(6):348-53. PubMed ID: 22124841
[TBL] [Abstract][Full Text] [Related]
7. Adrenal Molecular Imaging.
Sundin A
Front Horm Res; 2016; 45():70-9. PubMed ID: 27003680
[TBL] [Abstract][Full Text] [Related]
8. Differential diagnosis of adrenal mass using imaging modality: special emphasis on f-18 fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography.
Lee HJ; Lee J
Endocrinol Metab (Seoul); 2014 Mar; 29(1):5-11. PubMed ID: 24741448
[TBL] [Abstract][Full Text] [Related]
9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
10. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
Schaarschmidt BM; Grueneisen J; Heusch P; Gomez B; Umutlu L; Ruhlmann V; Rosenbaum-Krumme S; Antoch G; Buchbender C
Nucl Med Commun; 2015 Jun; 36(6):588-95. PubMed ID: 25759944
[TBL] [Abstract][Full Text] [Related]
11. Importance of adrenal incidentaloma in patients with a history of malignancy.
Frilling A; Tecklenborg K; Weber F; Kühl H; Müller S; Stamatis G; Broelsch C
Surgery; 2004 Dec; 136(6):1289-96. PubMed ID: 15657589
[TBL] [Abstract][Full Text] [Related]
12. Targeted Molecular Imaging in Adrenal Disease-An Emerging Role for Metomidate PET-CT.
Mendichovszky IA; Powlson AS; Manavaki R; Aigbirhio FI; Cheow H; Buscombe JR; Gurnell M; Gilbert FJ
Diagnostics (Basel); 2016 Nov; 6(4):. PubMed ID: 27869719
[TBL] [Abstract][Full Text] [Related]
13. A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses.
Sundin A; Hindié E; Avram AM; Tabarin A; Pacak K; Taïeb D
J Nucl Med; 2021 Jul; 62(Suppl 2):26S-33S. PubMed ID: 34230070
[TBL] [Abstract][Full Text] [Related]
14. Large adrenocortical adenoma with malignant features on imaging: A case report.
Koike S; Nakanishi S; Nohara S; Miyahira H; Tamaki T; Saito S
Urol Case Rep; 2022 Mar; 41():101968. PubMed ID: 34950566
[TBL] [Abstract][Full Text] [Related]
15. The role of PET in localization of neuroendocrine and adrenocortical tumors.
Eriksson B; Bergström M; Sundin A; Juhlin C; Orlefors H; Oberg K; Långström B
Ann N Y Acad Sci; 2002 Sep; 970():159-69. PubMed ID: 12381551
[TBL] [Abstract][Full Text] [Related]
16. Adrenocortical Positron Emission Tomography/PET-CT Imaging.
Kumar R; Alavi A; Fanti S
PET Clin; 2007 Jul; 2(3):331-9. PubMed ID: 27158014
[TBL] [Abstract][Full Text] [Related]
17.
Chen Cardenas SM; Santhanam P
Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
[TBL] [Abstract][Full Text] [Related]
18. Integration of molecular imaging in the personalized approach of patients with adrenal masses.
Lorusso M; Rufini V; DE Crea C; Pennestrì F; Bellantone R; Raffaelli M
Q J Nucl Med Mol Imaging; 2022 Jun; 66(2):104-115. PubMed ID: 35343669
[TBL] [Abstract][Full Text] [Related]
19. Contemporary imaging of incidentally discovered adrenal masses.
Wale DJ; Wong KK; Viglianti BL; Rubello D; Gross MD
Biomed Pharmacother; 2017 Mar; 87():256-262. PubMed ID: 28063406
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
